Teknova
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2451 Bert Dr, Hollister, California, 950...Phone Number
(831) 637-1100Website
www.teknova.comRevenue
$41.8 MillionStock Symbol
TKNOIndustry
ZI Rank: 10
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
7
7
10
8
13
10
About Teknova
Founded in 1996, Teknova specializes in providing critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein purification buffers, and molecular biology reagents for the life sciences and healthcare communities. The company is headquartered in Hollister, California.Explore more
Teknova Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teknova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Teknova launches new products
Website visits: Recent activity has been detected on your website
Check out if Teknova is spiking on competitors!
Earning: See what the market has to say on Teknova recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Teknova
Click to see if Teknova had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Teknova has new funding data
Teknova, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Teknova has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Teknova
Find more new buyers
Compare Similar Companies to Teknova
Compare insights from companies similar to Teknova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Teknova is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Teknova is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Teknova.
Teknova financials insights
Gather financial insights about Teknova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$96M
Teknova Tech Stack
A closer look at the technologies used by Teknova
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Hiring Plans
Teknova News & Media
Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
HOLLISTER, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, following the close of market.Alpha Teknova Conference: TKNO Targets EBITDA Profit by 2027 as Clinical Solutions Gains Traction
Alpha Teknova (NASDAQ:TKNO) outlined its growth strategy and path toward profitability during a company presentation, emphasizing a steady “Lab Essentials” foundation and a higher-growth “Clinical Solutions” segment tied to therapies and diagnostics moving through clinical development. 2025 resultsTeknova Reports Fourth Quarter and Full Year 2025 Financial Results
Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidance Fourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior year Company provides 2026 revenue guidance of $42-44 millionTeknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, following the close of market.
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teknova
Sign Up For FreeTo access detailed company insights
Founded in 1996, Teknova specializes in providing critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein purification buffers, and molecular biology reagents for the life sciences and healthcare communities. The company is headquartered in Hollister, Calif... Read More
